SecBot SecBot
6-K ·Filed Oct 15, 2026

AKZOY

AKZO NOBEL NV
NEUTRAL
Impact 3/10
Horizonmonths Processed11d 22h ago SEC0000950103-26-015660
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for regulatory approval milestones and the definitive proxy/prospectus for financial terms and synergy targets. The name announcement is a procedural step with no standalone trading catalyst.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+5d ⚠ clustered
AKZOY ▼ -0.41% at T+5d
NEUTRAL call -0.41% · α vs SPY -0.50% · entry $22.03 → $21.94
Next anchor: T+20d in 16d
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
-0.36%
call -0.36% · α -0.79%
$21.95
settled 11d ago
T+5d
-0.41%
call -0.41% · α -0.50%
$21.94
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

AkzoNobel (AKZOY) and Axalta (AXTA) announced the combined company will be named 'Axanzo' following their merger, which was announced in November 2025 and is expected to close in early 2027. The post-closing NYSE and Euronext Amsterdam ticker symbol will be AXZ. This is a branding update only — no financial terms, synergies, or regulatory milestones were disclosed, and both companies will continue operating independently until closing.

Key Facts

  • Combined company to be named 'Axanzo' after merger of AkzoNobel and Axalta
  • Post-closing NYSE and Euronext Amsterdam ticker symbol will be AXZ
  • Merger announced in November 2025; closing expected in early 2027
  • AkzoNobel CEO Greg Poux-Guillaume will be CEO of Axanzo; Axalta CEO Chris Villavarayan will be Deputy CEO
  • Both companies operate independently until all regulatory approvals and closing conditions are finalized
  • No financial terms, deal value, or synergy estimates provided in this filing

Financial Impact

No financial figures disclosed — this is a branding announcement only

Risk Factors

  • Regulatory approvals may be delayed or conditioned, pushing closing beyond early 2027
  • Integration risks post-closing could affect combined company performance
  • No deal valuation or exchange ratio disclosed in this filing

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0000950103-26-015660
Document: dp255052_6k.htm0000950103-26-015660
Document: 0000950103-26-015660-index-headers.html0000950103-26-015660
Document: 0000950103-26-015660-index.html0000950103-26-015660
Document: 0000950103-26-015660.txt0000950103-26-015660
12 reports for AKZOY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AKZOY — sortable, filterable
TypeNow
Oct 21, 2026
6d ago
6-K
MIXED ★ 5/10
$22.83awaiting T+5—$22.05 (−3.42%)
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 5/10
$22.83awaiting T+5—$22.05 (−3.42%)
Oct 21, 2026
6d ago
6-K
NEUTRAL ★ 5/10
$22.83awaiting T+5—$22.05 (−3.42%)
Oct 16, 2026
11d ago
6-K
NEUTRAL ★ 4/10
$22.03 $21.94▼ −0.41%▼ −0.50%$22.05 (+0.09%)
Oct 15, 2026
11d ago
6-K
NEUTRAL ★ 3/10
$22.03 $21.94▼ −0.41%▼ −0.50%$22.05 (+0.09%)
Oct 5, 2026
22d ago
6-K
BULLISH ★ 6/10
$21.53 $21.59▲ +0.28%▼ −0.14%$22.05 (+2.42%)
Aug 31, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$23.91 $23.61▼ −1.25%▼ −1.11%$22.05 (−7.78%)
Jul 23, 2026
13w ago
6-K
NEUTRAL ★ 3/10
$21.28 $23.56▲ +10.71%▲ +10.24%$22.05 (+3.62%)
Jul 22, 2026
13w ago
6-K
NEUTRAL ★ 5/10
$22.10 $23.23▲ +5.11%▲ +7.51%$22.05 (−0.23%)
Jul 22, 2026
13w ago
6-K
MIXED ★ 5/10
$22.10 $23.23▲ +5.11%▲ +7.51%$22.05 (−0.23%)
Showing 10 of 12

US Market Status

Market Open — Closes in 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026